Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

Malgorzata Pietruska, Jan Pietruski, K. Nagy, Michel Brecx, Nicole Birgit Arweiler, Anton Sculean

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10. 8 ± 1. 6 mm to 7. 4 ± 1. 6 mm (p <0. 001) and to 7. 6 ± 1. 7 mm (p <0. 001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10. 4 ± 1. 3 at baseline to 6. 9 ± 1. 0 mm (p <0. 001) at 1 year and 7. 2 ± 1. 2 mm (p <0. 001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i. e., in 8 out of 12) in the test group and in 75% of the defects (i. e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.

Original languageEnglish
Pages (from-to)1191-1197
Number of pages7
JournalClinical Oral Investigations
Volume16
Issue number4
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Dental Enamel
Periodontal Index
Control Groups
Gingival Recession
Chronic Periodontitis
Therapeutics
hydroxyapatite-beta tricalcium phosphate

Keywords

  • Biphasic calcium phosphate
  • Combination therapy
  • Controlled clinical study
  • Enamel matrix derivative
  • Intrabony defects
  • Regenerative periodontal therapy

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. / Pietruska, Malgorzata; Pietruski, Jan; Nagy, K.; Brecx, Michel; Arweiler, Nicole Birgit; Sculean, Anton.

In: Clinical Oral Investigations, Vol. 16, No. 4, 08.2012, p. 1191-1197.

Research output: Contribution to journalArticle

Pietruska, Malgorzata ; Pietruski, Jan ; Nagy, K. ; Brecx, Michel ; Arweiler, Nicole Birgit ; Sculean, Anton. / Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. In: Clinical Oral Investigations. 2012 ; Vol. 16, No. 4. pp. 1191-1197.
@article{08ce503b69474908a2e053bedc8af473,
title = "Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate",
abstract = "The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10. 8 ± 1. 6 mm to 7. 4 ± 1. 6 mm (p <0. 001) and to 7. 6 ± 1. 7 mm (p <0. 001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10. 4 ± 1. 3 at baseline to 6. 9 ± 1. 0 mm (p <0. 001) at 1 year and 7. 2 ± 1. 2 mm (p <0. 001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67{\%} of the defects (i. e., in 8 out of 12) in the test group and in 75{\%} of the defects (i. e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.",
keywords = "Biphasic calcium phosphate, Combination therapy, Controlled clinical study, Enamel matrix derivative, Intrabony defects, Regenerative periodontal therapy",
author = "Malgorzata Pietruska and Jan Pietruski and K. Nagy and Michel Brecx and Arweiler, {Nicole Birgit} and Anton Sculean",
year = "2012",
month = "8",
doi = "10.1007/s00784-011-0611-2",
language = "English",
volume = "16",
pages = "1191--1197",
journal = "Clinical Oral Investigations",
issn = "1432-6981",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

AU - Pietruska, Malgorzata

AU - Pietruski, Jan

AU - Nagy, K.

AU - Brecx, Michel

AU - Arweiler, Nicole Birgit

AU - Sculean, Anton

PY - 2012/8

Y1 - 2012/8

N2 - The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10. 8 ± 1. 6 mm to 7. 4 ± 1. 6 mm (p <0. 001) and to 7. 6 ± 1. 7 mm (p <0. 001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10. 4 ± 1. 3 at baseline to 6. 9 ± 1. 0 mm (p <0. 001) at 1 year and 7. 2 ± 1. 2 mm (p <0. 001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i. e., in 8 out of 12) in the test group and in 75% of the defects (i. e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.

AB - The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10. 8 ± 1. 6 mm to 7. 4 ± 1. 6 mm (p <0. 001) and to 7. 6 ± 1. 7 mm (p <0. 001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10. 4 ± 1. 3 at baseline to 6. 9 ± 1. 0 mm (p <0. 001) at 1 year and 7. 2 ± 1. 2 mm (p <0. 001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i. e., in 8 out of 12) in the test group and in 75% of the defects (i. e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.

KW - Biphasic calcium phosphate

KW - Combination therapy

KW - Controlled clinical study

KW - Enamel matrix derivative

KW - Intrabony defects

KW - Regenerative periodontal therapy

UR - http://www.scopus.com/inward/record.url?scp=84864288642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864288642&partnerID=8YFLogxK

U2 - 10.1007/s00784-011-0611-2

DO - 10.1007/s00784-011-0611-2

M3 - Article

C2 - 21881869

AN - SCOPUS:84864288642

VL - 16

SP - 1191

EP - 1197

JO - Clinical Oral Investigations

JF - Clinical Oral Investigations

SN - 1432-6981

IS - 4

ER -